Delivery Order SPE2DB22D2005-SPE2DB25FJRY0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,048.07. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,545.54 for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of August 25, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitive award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.72 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML KwikPen 3ML insulin pens. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,243.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens. This is a non-set-aside contract with an ultimate completion date of August 20, 2025, and performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply transaction supporting military and federal healthcare systems'...
- The Defense Logistics Agency awarded a $12,366.42 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of September 3, 2025. This competitive award, issued on September 2, 2025, carries no set-aside designation and utilizes firm fixed price terms typical of pharmaceutical procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,449.12 to AmerisourceBergen Drug Corp for Humalog 200 Unit/ML KwikPen 3ML insulin pens. This is a firm fixed price, non-competitive delivery order completed on August 28, 2025, with the pharmaceutical distributor fulfilling the order from its corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,815.02 to supply Humalog 100 Unit/mL KwikPen 3 mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, completed on August 1, 2025, and fulfills pharmaceutical supply requirements for federal medical procurement. The award leverages AmerisourceBergen's established capacity as a critical pharmaceutical distributor within the federal supply chain, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens at a firm fixed price of $2,082.52, with an ultimate completion date of July 21, 2025. This is a non-set-aside, competitively awarded contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,227.19 to supply Humalog 100 Unit/mL KwikPen 3mL insulin pens. This contract, which was not set-aside for small business, was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB24FTGQ9) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Humalog 100 unit/mL KwikPen 3mL insulin pens. The delivery order is valued at $1,024.32 and has a performance period through March 18, 2024. This delivery order is placed under a larger indefinite delivery contract (SPE2DB22D1103) awarded solely to AmerisourceBergen Drug Corp, with a potential value...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRY0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,283.00 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Humalog 200 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award represents a small-value transactional order typical of the company's ongoing pharmaceutical supply operations supporting federal medical procurement needs. This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs globally. The company serves as a critical vendor for the Defense Health Agency and other federal healthcare systems, with its federal contract portfolio demonstrating extensive capabilities across specialty medications, brand-name and generic drugs, and medical supplies. The DLA Troop Support Medical supply chain recognizes AmerisourceBergen as a primary pharmaceutical distributor essential to military readiness and veteran healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/18/25 |